Persistent Identifier
|
doi:10.7910/DVN/VANG2V |
Publication Date
|
2020-02-03 |
Title
| Data for: Dose Finding Study of Pentoxifylline in Children With Cerebral Malaria |
Author
| Olola, ChristopherKEMRI Centre for Geographic Medicine Research (Coast), Kilifi, Kenya
Kremsner, Peter GottfriedInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany
Winstanley, Peter A.University of Liverpool, Liverpool, United Kingdom
Wamola, BettyKEMRI Centre for Geographic Medicine Research (Coast), Kilifi, Kenya
Newton, Charles R.KEMRI Centre for Geographic Medicine Research (Coast), Kilifi, Kenya
Taylor, TerrieBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi |
Point of Contact
|
Use email button above to contact.
Olola, Christopher (KEMRI Centre for Geographic Medicine Research (Coast), Kilifi, Kenya)
Taylor, Terrie (Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi) |
Description
| Pentoxifylline (PTX) affects many processes that may contribute to the pathogenesis of severe malaria and it has been shown to reduce the duration of coma in children with cerebral malaria. This pilot study was performed to assess pharmacokinetics, safety and efficacy of PTX in African children with cerebral malaria.
Ten children admitted to the high dependency unit of the Kilifi District Hospital in Kenya with cerebral malaria (Blantyre coma score of 2 or less) received quinine plus a continuous infusion of 10 mg/kg/24 hours PTX for 72 hours. Five children were recruited as controls and received normal saline instead of PTX. Plasma samples were taken for PTX and tumour necrosis factor (TNF) levels. Blantyre Coma Score, parasitemia, hematology and vital signs were assessed 4 hourly.
The dataset contains:
- Demographic details of the patient, history of disease, and clinical findings (vital signs, oxygen saturation, respiratory status, Blantyre coma score recorded on admission
- Laboratory on admission included parasitaemia, full blood count and differential white cell count, glucose, blood culture, blood gas analysis, electrolytes, creatinine, lactate, and aspartate transaminase (AST). Parasite density was counted per 100 white blood cells or, for high parasitaemia, per 500 red blood cells and expressed in parasites per μL
A detailed description of the study design is given in the study protocol and results as reported by Lell, B., Köhler, C., Wamola, B., Olola, C.H., Kivaya, E., Kokwaro, G., Wypij, D., Mithwani, S., Taylor, T.E., Kremsner, P.G. and Newton, C.R., 2010. Pentoxifylline as an adjunct therapy in children with cerebral malaria. Malaria journal, 9(1), p.368. doi: 10.1186/1475-2875-9-368. The study is also registered on ClinicalTrials.gov NCT00133393. |
Subject
| Medicine, Health and Life Sciences |
Related Publication
| Lell, B., Köhler, C., Wamola, B., Olola, C.H., Kivaya, E., Kokwaro, G., Wypij, D., Mithwani, S., Taylor, T.E., Kremsner, P.G. and Newton, C.R., 2010. Pentoxifylline as an adjunct therapy in children with cerebral malaria. Malaria journal, 9(1), p.368 doi 10.1186/1475-2875-9-368 https://dx.doi.org/10.1186%2F1475-2875-9-368 |
Funding Information
| National Institute of Health: U01 grant AI045955 |
Depositor
| Taylor, Terrie |
Deposit Date
| 2020-01-30 |